Tag Archives: Opioid

Viewpoints: Simplify Regulations That Keep Diagnostic Innovations Out Of Hands Of U.S. Physicians; New Opioid Policies Bring Harm To Patients Who Need Them

Editorial writers focus on these health topics and others. Stat: Diagnostic Innovations Are Slowed By Bureaucratic Roadblocks Imagine, for a minute, that you are a cardiologist working in the emergency department of a busy hospital. You have several patients with chest pain: some of them are having heart attacks, or are about to; others have… Read More »

Massachusetts Maternal Mortality Rates Rising: Opioid Abuse and Psychiatric Illness Play a Role

Pregnancy-associated mortality, defined as the death of a woman during pregnancy or within one year of the termination of pregnancy, is increasing in Massachusetts.  In 2012, there were 30.4 deaths/100,000 live births. In 2014, the rate increased by 33%, to 40.4 deaths per 100,000 live births. Because pregnancy-associated mortality rates have historically been relatively low… Read More »

FDA declines to approve Mallinckrodt's abuse-deterrent opioid painkiller

(Reuters) – The U.S. Food and Drug Administration has declined to approve an abuse-deterrent version of Mallinckrodt Plc’s opioid painkiller Roxicodone, saying some parts of the company’s application need further evaluation. The treatment is a reformulated version of the company’s commonly abused painkiller Roxicodone, intended to make the drug less desirable and more difficult to… Read More »